Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2022 | Late chemotherapy and endocrine therapy toxicities

Galina Velikova, MD, PhD, St. James’s University Hospital Leeds, Leeds, UK, talks on the main issues with late chemotherapy toxicities, including neuropathy, fatigue and, for younger patients, early menopause. Dr Velikova also discusses side effects of endocrine treatment. Importantly, adherence to treatment is dependent on improving the control of side effects. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.